Target Of Rapamycin (TOR) signal transduction has an evolutionary conserved role in the control of growth, metabolism and ageing depending on nutrient availability. We aim at promoting a Science Club on TOR signal transduction in France, "le TOR de France". The goal is to gather students, postdocs, group leaders working in the field of TOR, nutrition, growth, development with approaches of cellular and molecular biology, genetics, evolution and the applications in medicine, pharmacology, human health. The first edition of the TOR de France meeting will cover multiple areas of investigation including: Molecular mechanisms of cell growth control across species Genetic alterations of TOR signal transduction in human diseases Link between caloric restriction and ageing Therapeutic strategies to inhibit TOR signal transduction in cancer and metabolic syndromes The scientific committee comprises 17 recognized scientists working in French Academic Institutions and Hospitals. International leaders, such as Brendan Manning (Harvard Medical School, US) and the 2017 Lasker award Mike Hall (Basel Biozentrum, Switzerland), will present keynote lectures at the meeting.